Ever After Foods Revolutionizes Cultivated Meat Production with $10 Million Investment
June 20, 2024, 3:36 am
Location: Israel, Haifa District, Haifa
Employees: 11-50
Founded date: 2022
Total raised: $10M
Ever After Foods, a subsidiary of Pluri Inc., secures a $10 million funding round to accelerate the growth of its bioreactor platform, making cultivated meat production more cost-efficient and scalable. The investment, led by global partners, marks a significant milestone in the company's mission to transform the meat industry.
Ever After Foods, a biotechnology company based in Israel, has received a $10 million strategic investment to enhance its innovative bioreactor platform for cultivated meat production. The funding round, led by U.S. and EU strategic investors, aims to address scalability challenges faced by the cultivated food industry and propel Ever After Foods as a technology enabler in the global market.
The unique production platform developed by Ever After Foods, in collaboration with Pluri and Tnuva Group, has revolutionized the way cultivated meat is produced. By leveraging Pluri's cutting-edge technology, Ever After Foods has achieved a 90% reduction in production costs while significantly increasing productivity. The bioreactors developed by the company yield up to six times more protein and 700 times more lipids from each cell, offering enhanced nutritional value and flavor.
Eyal Rosenthal, CEO of Ever After Foods, expressed his excitement about the new investment, stating that the shift to a technology enabler will allow the company to serve more players in the value chain. The partnership with global multinational companies, alongside Tnuva and Pluri, underscores the importance of collaboration in ensuring a sustainable and secure global food system.
With the extension of the license field to include cultivated fish, Ever After Foods is poised to expand its reach and impact in the food industry. The company's focus on developing a cost-efficient and scalable technology platform has positioned it as a leader in the cultivated meat sector, driving the next era of sustainable meat production.
The investment in Ever After Foods reflects Pluri's commitment to innovation and excellence, as highlighted by CEO and President Yaky Yanay. The company's patented 3D cell expansion technology has played a pivotal role in transforming the cultivated meat industry, paving the way for a more sustainable and ethical approach to meat production.
As the demand for alternative protein sources continues to grow, Ever After Foods' bioreactor platform offers a promising solution to the scalability and cost challenges faced by the cultivated meat industry. With the support of new global partners and renewed commitment from existing investors, the company is well-positioned to drive the next phase of growth and innovation in the cultivated food sector.
In conclusion, Ever After Foods' $10 million investment marks a significant milestone in the company's journey to revolutionize cultivated meat production. By leveraging cutting-edge technology and strategic partnerships, the company is poised to lead the way in sustainable and scalable meat production, paving the path for a more ethical and environmentally friendly food system.
Ever After Foods, a biotechnology company based in Israel, has received a $10 million strategic investment to enhance its innovative bioreactor platform for cultivated meat production. The funding round, led by U.S. and EU strategic investors, aims to address scalability challenges faced by the cultivated food industry and propel Ever After Foods as a technology enabler in the global market.
The unique production platform developed by Ever After Foods, in collaboration with Pluri and Tnuva Group, has revolutionized the way cultivated meat is produced. By leveraging Pluri's cutting-edge technology, Ever After Foods has achieved a 90% reduction in production costs while significantly increasing productivity. The bioreactors developed by the company yield up to six times more protein and 700 times more lipids from each cell, offering enhanced nutritional value and flavor.
Eyal Rosenthal, CEO of Ever After Foods, expressed his excitement about the new investment, stating that the shift to a technology enabler will allow the company to serve more players in the value chain. The partnership with global multinational companies, alongside Tnuva and Pluri, underscores the importance of collaboration in ensuring a sustainable and secure global food system.
With the extension of the license field to include cultivated fish, Ever After Foods is poised to expand its reach and impact in the food industry. The company's focus on developing a cost-efficient and scalable technology platform has positioned it as a leader in the cultivated meat sector, driving the next era of sustainable meat production.
The investment in Ever After Foods reflects Pluri's commitment to innovation and excellence, as highlighted by CEO and President Yaky Yanay. The company's patented 3D cell expansion technology has played a pivotal role in transforming the cultivated meat industry, paving the way for a more sustainable and ethical approach to meat production.
As the demand for alternative protein sources continues to grow, Ever After Foods' bioreactor platform offers a promising solution to the scalability and cost challenges faced by the cultivated meat industry. With the support of new global partners and renewed commitment from existing investors, the company is well-positioned to drive the next phase of growth and innovation in the cultivated food sector.
In conclusion, Ever After Foods' $10 million investment marks a significant milestone in the company's journey to revolutionize cultivated meat production. By leveraging cutting-edge technology and strategic partnerships, the company is poised to lead the way in sustainable and scalable meat production, paving the path for a more ethical and environmentally friendly food system.